Dovitinib (lactate hydrate)
Dovitinib lactate hydrate (TKI258 lactate hydrate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively[1].
Product Specifications
CAS Number
915769-50-5
Product Name Alternative
TKI258 (lactate hydrate) ; CHIR-258 (lactate hydrate)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
C-Kit; FGFR; FLT3; PDGFR; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dovitinib-lactate-hydrate.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(C(F)=CC=C2)C(N)=C1C3=NC4=CC=C(N5CCN(C)CC5)C=C4N3.CC(O)C(O)=O.[H]O[H]
Molecular Formula
C24H29FN6O5
Molecular Weight
500.52
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
PDGFRα; PDGFRβ; VEGFR1/Flt-1; VEGFR2/KDR/Flk-1; VEGFR3/Flt-4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
S100B (Astrocyte and Melanoma Marker), CF568 conjugate, 0.1mg/mL
